Analysts up AmSurg’s price target to $60.67

Twelve analysts have raised their rating of AmSurg stock to “buy,” according to a Sleek Money report.

Advertisement

The average 12-month price target on the company stock within the last year is $60.67, according to the report. The company has a one-year high of $62.83 and a one-year low of $40.

More articles on transactions and valuation issues:
AmSurg CAO sells nearly 9k shares
5 recent ASC company acquisitions & partnerships
Park Hill – MOB and ASC open in Fort Worth: 8 key points

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.